Ticker
  • Companies
  • RNS
  • AI Chat
  • Research
  • Indices
  • Ticker TV
  • Events
  • Commodities
  • Currencies
Ticker
⌘K
Developer PortalNewsServices
/Equities/AIMX/GDR
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Genedrive PLC logo
Genedrive PLC
/Equities/AIMX/GDR
OverviewShare PriceRNSTradesShort InterestDirectorsHoldings
Genedrive PLC logo

Genedrive PLC

Loading price data...
--
--

Price Chart

Open
0.95
High
0.99
Low
0.90
Close
0.99
Change
-0.05 (-5.26%)
Volume
5,569,813

Recent RNS announcements

16 Apr 202607:00:07CYP2C19 kit implemented in North Bristol NHS Trust
30 Mar 202607:00:10Interim Results to 31 December 2025
12 Mar 202609:52:57Holding(s) in Company
12 Mar 202607:00:11Holding(s) in Company
11 Mar 202615:22:08Holding(s) in Company

Annual Reports

22 Dec 2025Annual Report and Accounts (to 2025-06-30)
23 Dec 2024Annual Report and Accounts (to 2024-06-30)
2 Jan 2024Annual Report and Accounts (to 2023-06-30)

Directors (6)

DI
Dr Ian David GilhamNon-Executive Director
11 yrs 5 mos
TL
Thomas LindsayNon-Executive Director
8 yrs
CH
Chris Henry Francis YatesNon-Executive Director
7 yrs 8 mos
RJ
Russell John ShawExecutive Director
4 yrs
DG
Dr Gino MieleExecutive Director
2 yrs 7 mos

In the Press

5 Feb 2020Western market progress but developing markets difficultHardman & Co.
21 Nov 2019Regulatory hurdle leaped: hearing loss assayHardman & Co.
28 Oct 2019Acceleration of news flow expectedHardman & Co.
18 Jul 2019Hepatitis C market frustrationsHardman & Co.
8 Apr 2019First commercial sales in new focus area: bio-threatsHardman & Co.
10 Dec 2018Accelerating into fiscal 2019 with first salesHardman & Co.

Company details

genedrive plc is a company that specializes in molecular diagnostics. They are focused on creating a point-of-need platform that is affordable, fast, flexible, user-friendly, and reliable. This platform is designed to diagnose infectious diseases, as well as to help with patient stratification, pathogen detection, and other medical needs.

Industry
Health Care
Sector
Health Care
LEI
213800ZYODIRZ87Y4K14
Region
Europe
Admission date
4 Apr 2007
Website
www.genedriveplc.com
X
@genedriveplc

Shares details

Shares in issue
1,029,603,992
Last updated: 17 April 2026

Instrument details

ISIN
GB00B1VKB244
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Loading price data...
--
--

Price Chart

Open
0.95
High
0.99
Low
0.90
Close
0.99
Change
-0.05 (-5.26%)
Volume
5,569,813

Recent RNS announcements

16 Apr 202607:00:07CYP2C19 kit implemented in North Bristol NHS Trust
30 Mar 202607:00:10Interim Results to 31 December 2025
12 Mar 202609:52:57Holding(s) in Company
12 Mar 202607:00:11Holding(s) in Company
11 Mar 202615:22:08Holding(s) in Company

Annual Reports

22 Dec 2025Annual Report and Accounts (to 2025-06-30)
23 Dec 2024Annual Report and Accounts (to 2024-06-30)
2 Jan 2024Annual Report and Accounts (to 2023-06-30)

Directors (6)

DI
Dr Ian David GilhamNon-Executive Director
11 yrs 5 mos
TL
Thomas LindsayNon-Executive Director
8 yrs
CH
Chris Henry Francis YatesNon-Executive Director
7 yrs 8 mos
RJ
Russell John ShawExecutive Director
4 yrs
DG
Dr Gino MieleExecutive Director
2 yrs 7 mos

In the Press

5 Feb 2020Western market progress but developing markets difficultHardman & Co.
21 Nov 2019Regulatory hurdle leaped: hearing loss assayHardman & Co.
28 Oct 2019Acceleration of news flow expectedHardman & Co.
18 Jul 2019Hepatitis C market frustrationsHardman & Co.
8 Apr 2019First commercial sales in new focus area: bio-threatsHardman & Co.
10 Dec 2018Accelerating into fiscal 2019 with first salesHardman & Co.

Company details

genedrive plc is a company that specializes in molecular diagnostics. They are focused on creating a point-of-need platform that is affordable, fast, flexible, user-friendly, and reliable. This platform is designed to diagnose infectious diseases, as well as to help with patient stratification, pathogen detection, and other medical needs.

Industry
Health Care
Sector
Health Care
LEI
213800ZYODIRZ87Y4K14
Region
Europe
Admission date
4 Apr 2007
Website
www.genedriveplc.com
X
@genedriveplc

Shares details

Shares in issue
1,029,603,992
Last updated: 17 April 2026

Instrument details

ISIN
GB00B1VKB244
Exchange
AIMX
Market
Aim
Market Segment
ASQ1
Market Sector
AMQ1
Share Price0.99p
Day Change-0.05p(-5.26%)
Market Cap£10.2m
17 Apr 15:14
Market closed
Share Price0.99p
Day Change-0.05p(-5.26%)
Market Cap£10.2m
17 Apr 15:14
Market closed